Compare MONDELEZ INTERNATIONAL INC Common Stock (MDLZ) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MONDELEZ INTERNATIONAL INC Common Stock vs Regeneron Pharmaceuticals Inc — how do they compare? MONDELEZ INTERNATIONAL INC Common Stock trades at $61.51 (market cap $79.91B), while Regeneron Pharmaceuticals Inc trades at $796.38 (market cap $83.19B). The key difference: MONDELEZ INTERNATIONAL INC Common Stock and Regeneron Pharmaceuticals Inc are close in size by market cap, and MONDELEZ INTERNATIONAL INC Common Stock pays the higher dividend (3.19%). Which is the better fit depends on your goals.
| MDLZ | REGN | |
|---|---|---|
Market Cap | $79.91B | $83.19B |
Sector | Consumer Staples | Health |
52-Week High | $64.99 | $812.27 |
52-Week Low | $51.51 | $555.51 |
Enterprise Value | $100.25B | $77.90B |
Dividend Yield | 3.19% | 0.47% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Regeneron Pharmaceuticals (REGN) trades at $784.36, up 1.59% today, with a bullish technical signal from moving averages but overbought RSI readings. The company shows strong profitability with a net income margin of 27.86% and has beaten EPS estimates in recent quarters. However, multiple class-action lawsuits filed in August 2026 allege inadequate clinical-trial risk disclosures, creating investor uncertainty amid solid financial performance.
Outlook remains supported by earnings momentum and analyst buy ratings, but legal risks and high valuation multiples pose near-term headwinds. Investment opportunity hinges on legal resolution and sustained drug pipeline success, while risks include trial setbacks and regulatory scrutiny.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About MONDELEZ INTERNATIONAL INC Common Stock
Mondelez has operated as an independent organization since its split from the former Kraft Foods North American grocery business in October 2012. The firm is a leading player in the global snack arena with a presence in the biscuit (47% of sales), chocolate (32%), gum/candy (10%), beverage (4%), and cheese and grocery (7%) aisles. Mondelez's portfolio includes well-known brands like Oreo, Chips Ahoy, Halls, Trident, and Cadbury, among others. The firm derives around one third of revenue from developing markets, nearly 40% from Europe, and the remainder from North America.
Read more on MDLZ →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
